Buy Zantac online without a doctor's prescription
- ED Sample Packs
- Erectile Dysfunction
- Anti Fungal
- Anti Viral
- Birth Control
- Blood Pressure
- Cholesterol Lowering
- Aciphex $0.56
- Allopurinol $0.67
- Bentyl $0.48
- Biaxin $2.40
- Brand Amoxil $0.57
- Carafate $1.53
- Cytotec $1.70
- Decadron $0.35
- Deltasone $0.29
- Diarex $24
- Ditropan $2.30
- Doxazosin $0.33
- Florinef $1.03
- Gasex $25
- Hytrin $0.73
- Lasuna $25
- Metoclopramide $0.57
- Motilium $0.27
- Nexium $0.43
- Nitrofurantoin $0.43
- Noroxin $0.38
- Pariet $0.40
- Prednisolone $0.32
- Prevacid $0.42
- Prilosec $0.49
- Protonix $0.37
- Pyridium $0.74
- Ranitidine $0.30
- Reglan $0.37
- Renagel $3.00
- Roxithromycin $0.78
- Torsemide $0.34
- Zantac $0.15
- Hair Loss
- Heart Disease
- Man's Health
- Muscle Relaxant
- Pain Relief
- Sleep Aid
- Quit Smoking
- Weight Loss
- Woman's Health
Zantac is prescribed for treatment and prevention of ulcers in the stomach and intestines, it works decreasing amount of acid in the stomach.
Active Ingredient: Ranitidine
Availability: In Stock (31 Packages)
|Product name||Per Pill||Savings (only today)||Per Pack|
|60 pills||$0.56||$33.36||ADD TO CART|
|90 pills||$0.43||$11.01||$50.04 $39.03||ADD TO CART|
|120 pills||$0.37||$22.02||$66.72 $44.70||ADD TO CART|
|180 pills||$0.31||$44.03||$100.07 $56.04||ADD TO CART|
|270 pills||$0.27||$77.05||$150.10 $73.05||ADD TO CART|
|360 pills||$0.25||$110.08||$200.14 $90.06||ADD TO CART|
What is Zantac?
Zantac is an anti-ulcer agent, histamine H2 receptor blocker.
Ranitidine is an active substance of Zantac, is a blocker of histamine H2 receptors. It helps reduce basal and stimulated food load, irritation of baroreceptors, gastrin, histamine and other biogenic stimulators of hydrochloric acid secretion.
Indication for use
- Duodenal ulcer associated with Helicobacter pylori infection;
- Duodenal ulcer and benign expressions of the stomach, including those that occurred while taking nonsteroidal anti-inflammatory drugs (NSAIDs);
- Gastroesophageal reflux disease, including the relief of pain;
- Postoperative ulcers;
- Reflux esophagitis;
- Chronic episodic dyspepsia, occurring with chest or epigastric pain (not related to the above), which interfere with sleep or are associated with food intake;
- Zollinger-Ellison syndrome;
- Prevention of stressful stomach ulcers in patients with serious illnesses;
- Prevention of duodenal ulcers with the use of NSAIDs (including acetylsalicylic acid), especially with a history of ulcer disease;
- Prevention of recurrent bleeding from peptic ulcers;
- Prevention of aspiration of acidic contents of the stomach during general anesthesia (Mendelssohn’s syndrome).
- Acute porphyria (including history);
- Period of pregnancy and breastfeeding;
- Age up to 12 years;
- Hypersensitivity to the drug.
It should be used with caution in patients with hepatic and renal insufficiency, cirrhosis of the liver with a history of portosystemic encephalopathy.
- The use of Zantac is able to hide the symptoms of carcinoma of the stomach, therefore, patients with a stomach ulcer or new signs of dyspepsia in the elderly and middle age are advised to rule out the possibility of malignancy before starting treatment.
- Because of the risk of ricochet syndrome, Zantac should be discontinued, gradually reducing the dose.
- Simultaneous reception of ranitidine with NSAIDs must be accompanied by regular monitoring of patients, especially in old age and with a peptic ulcer in history.
- Effervescent tablets should be taken with caution in patients with sodium restriction, with phenylketonuria.
- It is not recommended to use Zantac before diagnosing skin samples to detect an allergic skin reaction of the immediate type.
- Patients with severe renal insufficiency need to be adjusted dosing regimen.
- An increase in the level of hepatic transaminases can be observed when parenterally administered with high doses of the drug for more than 5 days.
- The use of Zantac can cause an increase in glutamate transpeptidase activity or cause a false-positive reaction when testing for the presence of protein in the urine.
- In tobacco-dependent patients, the effectiveness of Zantac therapy is reduced.
- During the period of treatment the patient should not eat foods, drinks and medicines that cause irritation of the gastric mucosa.
- During the use of Zantac, the patient cannot engage in potentially hazardous activities that require concentration of attention and high speed of psychomotor reactions.
- Ranitidine crosses the placenta and is excreted in breast milk.
- Pregnancy is a contraindication to taking the drug. Zantac can only be prescribed if the doctor assesses the expected benefit to the mother above the possible harm to the fetus.
- During lactation, Zantac is contraindicated.
- Patients under the age of 12 are not assigned to Zantac.
- In renal failure, Zantac is prescribed with caution.
- In patients with hepatic insufficiency and in patients with cirrhosis of the liver with a history of portosystemic encephalopathy, caution is required during therapy.
- Elderly patients with the combined use of Zantac with NSAIDs require regular monitoring.
How to use?
The recommended dosing of Zantac for adult patients:
- Exacerbation of benign gastric and duodenal ulcers: 150 mg 2 times a day (morning and evening) or 300 mg 1 time per day (overnight) for 4 weeks. In the absence of complete scarring of the ulcer, treatment should be extended for another 4 weeks. For the treatment of duodenal ulcers, a dose of 300 mg 2 times a day is more effective (an increase in dose does not affect the incidence of undesirable effects);
- Long-term prevention of recurrence of gastric and duodenal ulcers: 150 mg 1 time per day (at night), for smoking patients, the dose is increased to 300 mg 1 time per day;
- Ulcers associated with taking NSAIDs: 150 mg 2 times a day or 300 mg 1 time a day (at night). The course of treatment is 8-12 weeks;
- Prevention of ulcers with the use of NSAIDs: 150 mg 2 times a day during the entire period of taking NSAIDs;
- Duodenal ulcer associated with Helicobacter pylori: 150 mg 2 times a day or 300 mg 1 time a day in combination with 750 mg amoxicillin 3 times a day and 500 mg metronidazole 3 times a day. The course of treatment is 2 weeks; in the next 2 weeks, Zantacom monotherapy;
- Postoperative ulcers: 150 mg 2 times a day, the duration of therapy is 4 weeks. In the absence of a clinical effect, the treatment is extended for another 4 weeks;
- Gastroesophageal reflux disease: 150 mg: in acute form – 2 times a day (or 1 time per day (at night) in a dose of 300 mg), the course of treatment is 8-12 weeks; with severe and moderate reflux esophagitis – 4 times a day with a duration of therapy of 12 weeks; for relief of pain, 2 times a day for 2-4 weeks; for prophylaxis – 2 times a day;
- Zollinger-Ellison syndrome: initial dose – 150 mg 3 times a day, if necessary, you can increase the daily dose to 6000 mg;
- Chronic episodic dyspepsia: 150 mg 2 times a day, the course of treatment is 6 weeks. In the absence of a clinical effect or deterioration of the condition, an additional examination is necessary;
- Prevention of recurrent bleeding from peptic ulcers and bleeding stress ulcers in critically ill patients: after transferring the patient to an oral meal, parenteral therapy is replaced with the intake of Zantac by 150 mg 2 times a day;
- Prevention of Mendelssohn’s syndrome: 150 mg on the eve (in the evening) and 2 hours before general anesthesia, parenteral administration is possible; during labor – 150 mg every 6 hours (if necessary, general anesthesia shows the simultaneous use of Zantac and water-soluble antacids (sodium citrate).
In peptic ulcers in children, Zantac is prescribed taking into account the weight of the child at a dose of 2-4 mg per 1 kg 2 times a day, but not more than 300 mg per day.
In severe renal insufficiency (creatinine clearance (CC) less than 50 ml / min), the plasma concentration of ranitidine increases, so the dose should be 150 mg 1 time per day.
When a patient is on long-term hemodialysis or ambulatory peritoneal dialysis, Zantac is prescribed immediately after the end of the session at a dose of 150 mg
- Cardiovascular system: arrhythmia, lowering blood pressure (BP), bradycardia, atrioventricular (AV) block; rarely – vasculitis;
- Digestive system: dry mouth, nausea, vomiting, abdominal pain, constipation, reversible transient changes in liver function tests; in some cases, the development of usually reversible, cholestatic, hepatocellular or mixed hepatitis, with or without jaundice; rarely, acute pancreatitis, diarrhea;
- Blood system: thrombocytopenia, leukopenia; rarely, pancytopenia, agranulocytosis; sometimes – immune hemolytic anemia, aplasia and hypoplasia of the bone marrow;
- Musculoskeletal system: rarely – myalgia, arthralgia;
- Nervous system: increased fatigue, headache (sometimes severe), drowsiness, dizziness; rarely – tinnitus, irritability, blurred vision, involuntary movements, reversible motor disorders of an involuntary nature; more often in elderly and seriously ill patients – hallucinations, confusion, depression;
- Dermatological reactions: alopecia;
- Endocrine system: gynecomastia, hyperprolactinemia, decreased libido, amenorrhea; rarely, swelling or discomfort in the male glands, reversible impotence;
- Allergic reactions: urticaria, skin rash, bronchospasm, erythema multiforme, angioedema, anaphylactic shock, fever, arterial hypotension, chest pain.